Cerebrospinal fluid proteomics in patients with Alzheimer’s disease reveals five molecular subtypes with distinct genetic risk profiles

Betty M. Tijms, Pieter Jelle Visser, Luigi Lorenzini et al.|Nature Aging|2024

Cited by 195